UnitedHealth (UNH) Closes DaVita Unit Buy, Expands OptumCare
Zacks Investment Research | Jun 26, 2019 06:12AM ET
UnitedHealth Group Inc.’s (NYSE:UNH) Optum unit has completed the buyout of DaVita Medical Group, a unit of DaVita Inc. (NYSE:DVA) , for $4.3 billion in cash.
This acquisition has been made by OptumCare — a sub-segment of Optum — the company’s health services segment. OptumCare provides primary and urgent care delivery services business. It will expand UnitedHealth’s ambulatory care services operations.
With this deal, UnitedHealth will now be able to pair DaVita Medical Group’s 300 medical clinics, 35 urgent-care centers, and six outpatient surgery centers — which reach around 1.7 million patients a year — with Optum’s massive insurance division.
This acquisition is expected to aid the growth of OptumHealth, which is targeting double-digit percentage revenue growth on average and sustainable operating margins of 8% to 10% in the upcoming years. The unit continues to make productivity gains in its existing products and services while investing in new platforms and markets.
Numerous small mergers and acquisitions have strengthened UnitedHealth's existing business; provided a new platform for future growth; and brought tools, technologies or skills that could not be otherwise obtained or developed more efficiently. These business combinations are also necessary to control UnitedHealth’s soaring medical costs and protect its margins.
Effective use of capital is one of the drivers of UnitedHealth’s ability to achieve distinctive long-term financial performance, as reflected by revenue CAGR of 12% from 2006-2018.
Year to date, the stock has lost 0.6% compared with the industry ’s rise of 2.12%.
The inorganic growth strategy of the company has placed it at the highest echelon in the industry (in terms of medical members served and revenue), against companies like Cigna Corp. (NYSE:CI) , Anthem Inc. (NYSE:ANTM) , Humana (NYSE:HUM) and others.
Meanwhile, an increasing trend of consolidation is being witnessed across the industry, which is itself undergoing rapid transformation owing to heightened regulation, soaring medical costs, increased consumerism, and shift to value-based care. Some of the recently completed buyouts are that of Aetna Inc (NYSE:AET). by CVS Health Corp (NYSE:CVS)., and Express Scripts (NASDAQ:ESRX) by Cigna Corp. These deals have enabled the surviving entities to develop an ecosystem of healthcare services and derive efficiencies at each node.
Get The News You Want
UnitedHealth carries a Zacks Rank #3 (Hold).
You can see .
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.